Published in Int J Mol Sci on November 21, 2013
Emerging regulators of the inflammatory process in osteoarthritis. Nat Rev Rheumatol (2014) 1.15
Therapeutic Potential of Differentiated Mesenchymal Stem Cells for Treatment of Osteoarthritis. Int J Mol Sci (2015) 0.84
Green tea polyphenol treatment is chondroprotective, anti-inflammatory and palliative in a mouse post-traumatic osteoarthritis model. Arthritis Res Ther (2014) 0.82
Randomized controlled studies on the efficacy of antiarthritic agents in inhibiting cartilage degeneration and pain associated with progression of osteoarthritis in the rat. Arthritis Res Ther (2016) 0.77
Procyanidins Mitigate Osteoarthritis Pathogenesis by, at Least in Part, Suppressing Vascular Endothelial Growth Factor Signaling. Int J Mol Sci (2016) 0.75
Insights into the Action Mechanisms of Traditional Chinese Medicine in Osteoarthritis. Evid Based Complement Alternat Med (2017) 0.75
Bioactive Plant Metabolites in the Management of Non-Communicable Metabolic Diseases: Looking at Opportunities beyond the Horizon. Metabolites (2015) 0.75
The impact of polyphenols on chondrocyte growth and survival: a preliminary report. Food Nutr Res (2015) 0.75
Relationship between soy milk intake and radiographic knee joint space narrowing and osteophytes. Rheumatol Int (2016) 0.75
Nutritional advantages of sous-vide cooking compared to boiling on cereals and legumes: Determination of ashes and metals content in ready-to-eat products. Food Sci Nutr (2017) 0.75
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum (2008) 19.80
Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med (2006) 10.95
Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum (2001) 5.24
Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol (2010) 5.14
Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum (2012) 4.28
The role of cytokines in osteoarthritis pathophysiology. Biorheology (2002) 4.28
Tumour necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature (1986) 4.24
Synovial tissue inflammation in early and late osteoarthritis. Ann Rheum Dis (2005) 3.25
Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappaB: differential regulation of collagenase 1 and collagenase 3. Arthritis Rheum (2000) 3.23
Insurer and out-of-pocket costs of osteoarthritis in the US: evidence from national survey data. Arthritis Rheum (2009) 3.08
Avocado soybean unsaponifiables (ASU) suppress TNF-alpha, IL-1beta, COX-2, iNOS gene expression, and prostaglandin E2 and nitric oxide production in articular chondrocytes and monocyte/macrophages. Osteoarthritis Cartilage (2007) 3.04
Nitric oxide scavenging by curcuminoids. J Pharm Pharmacol (1997) 3.01
Proanthocyanidins--a final frontier in flavonoid research? New Phytol (2005) 2.96
Effects of a ginger extract on knee pain in patients with osteoarthritis. Arthritis Rheum (2001) 2.95
In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice. J Nutr Biochem (2005) 2.71
Cartilage homeostasis in health and rheumatic diseases. Arthritis Res Ther (2009) 2.44
The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial. Arthritis Rheum (2008) 2.37
Free radical scavenging activity of curcuminoids. Arzneimittelforschung (1996) 2.34
Effect of a topical herbal cream on the pain and stiffness of osteoarthritis: a randomized double-blind, placebo-controlled clinical trial. J Clin Rheumatol (2003) 2.08
NF-kappaB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis. Osteoarthritis Cartilage (2006) 2.07
Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum (2009) 2.03
The structure and function of cartilage proteoglycans. Eur Cell Mater (2006) 1.93
Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis. Suppression of collagenase-1 expression. Arthritis Rheum (1996) 1.89
The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation. Osteoarthritis Cartilage (2001) 1.86
Reactive oxygen species mediate cytokine activation of c-Jun NH2-terminal kinases. J Biol Chem (1996) 1.85
Glucosamine inhibits IL-1beta-induced NFkappaB activation in human osteoarthritic chondrocytes. Osteoarthritis Cartilage (2003) 1.79
Bone remodelling in osteoarthritis. Nat Rev Rheumatol (2012) 1.76
Metabolic syndrome meets osteoarthritis. Nat Rev Rheumatol (2012) 1.75
Mechanisms of disease: role of chondrocytes in the pathogenesis of osteoarthritis--structure, chaos and senescence. Nat Clin Pract Rheumatol (2007) 1.74
Suppression of NF-kappaB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis. Biochem Pharmacol (2007) 1.73
A randomized, placebo-controlled, cross-over study of ginger extracts and ibuprofen in osteoarthritis. Osteoarthritis Cartilage (2000) 1.60
Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee--a randomized double blind placebo controlled trial. Phytomedicine (2003) 1.59
Synergistic chondroprotective effects of curcumin and resveratrol in human articular chondrocytes: inhibition of IL-1beta-induced NF-kappaB-mediated inflammation and apoptosis. Arthritis Res Ther (2009) 1.56
The role of the cartilage matrix in osteoarthritis. Nat Rev Rheumatol (2010) 1.54
Osteoarthritis and nutrition. From nutraceuticals to functional foods: a systematic review of the scientific evidence. Arthritis Res Ther (2006) 1.53
Pharmaceutical therapy for osteoarthritis. PM R (2012) 1.52
Regulation of inflammation signalling by resveratrol in human chondrocytes in vitro. Biochem Pharmacol (2007) 1.51
Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT. Ann Rheum Dis (2010) 1.51
Involvement of the Wnt signaling pathway in experimental and human osteoarthritis: prominent role of Wnt-induced signaling protein 1. Arthritis Rheum (2009) 1.50
Suppression of the nuclear factor-kappaB activation pathway by spice-derived phytochemicals: reasoning for seasoning. Ann N Y Acad Sci (2004) 1.49
Detection of nitrotyrosine in aging and osteoarthritic cartilage: Correlation of oxidative damage with the presence of interleukin-1beta and with chondrocyte resistance to insulin-like growth factor 1. Arthritis Rheum (2002) 1.49
Modulation by interleukin 1 and tumor necrosis factor alpha of production of collagenase, tissue inhibitor of metalloproteinases and collagen types in differentiated and dedifferentiated articular chondrocytes. Biochim Biophys Acta (1990) 1.45
Post-traumatic osteoarthritis: the role of stress induced chondrocyte damage. Biorheology (2006) 1.44
Epidemiology of osteoarthritis and associated comorbidities. PM R (2012) 1.42
Does vitamin D improve osteoarthritis of the knee: a randomized controlled pilot trial. Clin Orthop Relat Res (2013) 1.39
Resveratrol suppresses interleukin-1beta-induced inflammatory signaling and apoptosis in human articular chondrocytes: potential for use as a novel nutraceutical for the treatment of osteoarthritis. Biochem Pharmacol (2008) 1.37
Oxidant conditioning protects cartilage from mechanically induced damage. J Orthop Res (2010) 1.36
Inhibition of UVB-induced oxidative stress-mediated phosphorylation of mitogen-activated protein kinase signaling pathways in cultured human epidermal keratinocytes by green tea polyphenol (-)-epigallocatechin-3-gallate. Toxicol Appl Pharmacol (2001) 1.35
Ginger: an overview. Am Fam Physician (2007) 1.30
Treatment of osteoarthritis with a herbomineral formulation: a double-blind, placebo-controlled, cross-over study. J Ethnopharmacol (1991) 1.29
Green tea polyphenol epigallocatechin-3-gallate (EGCG) differentially inhibits interleukin-1 beta-induced expression of matrix metalloproteinase-1 and -13 in human chondrocytes. J Pharmacol Exp Ther (2003) 1.29
Transcriptional suppression by interleukin-1 and interferon-gamma of type II collagen gene expression in human chondrocytes. J Cell Biochem (1994) 1.28
Mechanical loading, cartilage degradation, and arthritis. Ann N Y Acad Sci (2010) 1.26
Broad-spectrum matrix metalloproteinase inhibitor marimastat-induced musculoskeletal side effects in rats. Arthritis Rheum (2003) 1.26
Superoxide dismutase downregulation in osteoarthritis progression and end-stage disease. Ann Rheum Dis (2010) 1.25
Sulfur in human nutrition and applications in medicine. Altern Med Rev (2002) 1.24
TNFalpha suppresses link protein and type II collagen expression in chondrocytes: Role of MEK1/2 and NF-kappaB signaling pathways. J Cell Physiol (2003) 1.22
An in vivo rabbit model for cartilage trauma: a preliminary study of the influence of impact stress magnitude on chondrocyte death and matrix damage. J Orthop Trauma (2005) 1.21
Sp1 and Sp3 transcription factors mediate interleukin-1 beta down-regulation of human type II collagen gene expression in articular chondrocytes. J Biol Chem (2003) 1.21
Aging processes and the development of osteoarthritis. Curr Opin Rheumatol (2013) 1.18
Anti-inflammatory effects of a stabilized lipid extract of Perna canaliculus (Lyprinol). Allerg Immunol (Paris) (2000) 1.17
Biological actions of curcumin on articular chondrocytes. Osteoarthritis Cartilage (2009) 1.16
Joint fluid antioxidants are decreased in osteoarthritic joints compared to joints with macroscopically intact cartilage and subacute injury. Osteoarthritis Cartilage (2008) 1.16
Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial. Osteoarthritis Cartilage (2005) 1.16
Curcumin modulates nuclear factor kappaB (NF-kappaB)-mediated inflammation in human tenocytes in vitro: role of the phosphatidylinositol 3-kinase/Akt pathway. J Biol Chem (2011) 1.15
Molecular network of cartilage homeostasis and osteoarthritis. Med Res Rev (2008) 1.15
The use of ginger (Zingiber officinale Rosc.) as a potential anti-inflammatory and antithrombotic agent. Prostaglandins Leukot Essent Fatty Acids (2002) 1.14
OA clinical trials: current targets and trials for OA. Choosing molecular targets: what have we learned and where we are headed? Osteoarthritis Cartilage (2009) 1.14
Inflammatory signaling in cartilage: MAPK and NF-kappaB pathways in chondrocytes and the use of inhibitors for research into pathogenesis and therapy of osteoarthritis. Curr Drug Targets (2007) 1.13
A pilot study of tumor necrosis factor inhibition in erosive/inflammatory osteoarthritis of the hands. J Rheumatol (2007) 1.13
Effects of prodelphinidins isolated from Ribes nigrum on chondrocyte metabolism and COX activity. Naunyn Schmiedebergs Arch Pharmacol (2002) 1.13
Inhibition of the expression and activity of cyclooxygenase-2 by chicory extract. Biochem Biophys Res Commun (2005) 1.11
Short-term gene expression changes in cartilage explants stimulated with interleukin beta plus glucosamine and chondroitin sulfate. J Rheumatol (2006) 1.11
Pomegranate extract inhibits the interleukin-1β-induced activation of MKK-3, p38α-MAPK and transcription factor RUNX-2 in human osteoarthritis chondrocytes. Arthritis Res Ther (2010) 1.10
Successful treatment of inflammatory knee osteoarthritis with tumour necrosis factor blockade. Ann Rheum Dis (2006) 1.09
Resveratrol inhibits IL-1 beta-induced stimulation of caspase-3 and cleavage of PARP in human articular chondrocytes in vitro. Ann N Y Acad Sci (2007) 1.09
Bioassay-guided evaluation of antioxidant and antinociceptive activities of carvacrol. Basic Clin Pharmacol Toxicol (2010) 1.09
Expression of transient receptor potential vanilloid 1 (TRPV1) in synovial fibroblasts from patients with osteoarthritis and rheumatoid arthritis. Biochem Biophys Res Commun (2007) 1.08
6-Shogaol suppressed lipopolysaccharide-induced up-expression of iNOS and COX-2 in murine macrophages. Mol Nutr Food Res (2008) 1.07
An in vitro screening assay for inhibitors of proinflammatory mediators in herbal extracts using human synoviocyte cultures. In Vitro Cell Dev Biol Anim (2004) 1.06
Inhibition of lipid peroxidation and structure-activity-related studies of the dietary constituents anthocyanins, anthocyanidins, and catechins. J Agric Food Chem (2002) 1.06
Nitric oxide in inflammation and pain associated with osteoarthritis. Arthritis Res Ther (2008) 1.06
Symptomatic efficacy of avocado-soybean unsaponifiables (ASU) in osteoarthritis (OA) patients: a meta-analysis of randomized controlled trials. Osteoarthritis Cartilage (2007) 1.06
Vitamin E is ineffective for symptomatic relief of knee osteoarthritis: a six month double blind, randomised, placebo controlled study. Ann Rheum Dis (2001) 1.05
Interleukin-1beta-induced extracellular matrix degradation and glycosaminoglycan release is inhibited by curcumin in an explant model of cartilage inflammation. Ann N Y Acad Sci (2009) 1.04
Bromelain as a Treatment for Osteoarthritis: a Review of Clinical Studies. Evid Based Complement Alternat Med (2004) 1.03
Nutraceuticals: do they represent a new era in the management of osteoarthritis? - a narrative review from the lessons taken with five products. Osteoarthritis Cartilage (2010) 1.03
Association of plasma n-6 and n-3 polyunsaturated fatty acids with synovitis in the knee: the MOST study. Osteoarthritis Cartilage (2012) 1.02
Disease modifying osteoarthritis drugs: facing development challenges and choosing molecular targets. Curr Drug Targets (2010) 1.02
The clinical effectiveness of glucosamine and chondroitin supplements in slowing or arresting progression of osteoarthritis of the knee: a systematic review and economic evaluation. Health Technol Assess (2009) 1.01
Duhuo jisheng tang for treating osteoarthritis of the knee: a prospective clinical observation. Chin Med (2007) 1.01
S-adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: a double-blind cross-over trial. [ISRCTN36233495]. BMC Musculoskelet Disord (2004) 1.01
Curcumin inhibits pro-inflammatory mediators and metalloproteinase-3 production by chondrocytes. Inflamm Res (2009) 1.00
Dietary polyphenols and mechanisms of osteoarthritis. J Nutr Biochem (2012) 0.99
Selective inhibition of ADAMTS-1, -4 and -5 by catechin gallate esters. Eur J Biochem (2003) 0.99
Regulation of osteoarthritis by omega-3 (n-3) polyunsaturated fatty acids in a naturally occurring model of disease. Osteoarthritis Cartilage (2011) 0.99
Retracted Pathologic indicators of degradation and inflammation in human osteoarthritic cartilage are abrogated by exposure to n-3 fatty acids. Arthritis Rheum (2002) 0.99
Evidence of effectiveness of herbal antiinflammatory drugs in the treatment of painful osteoarthritis and chronic low back pain. Phytother Res (2007) 0.98
The impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosus. PLoS One (2010) 1.42
Activation of resorption in fatigue-loaded bone involves both apoptosis and active pro-osteoclastogenic signaling by distinct osteocyte populations. Bone (2012) 1.40
Tendon-derived stem/progenitor cell aging: defective self-renewal and altered fate. Aging Cell (2010) 1.39
Early response to tendon fatigue damage accumulation in a novel in vivo model. J Biomech (2009) 1.36
BMP-12 treatment of adult mesenchymal stem cells in vitro augments tendon-like tissue formation and defect repair in vivo. PLoS One (2011) 1.29
Physiological loading of joints prevents cartilage degradation through CITED2. FASEB J (2010) 1.12
Matrix metalloproteinase-3 in articular cartilage is upregulated by joint immobilization and suppressed by passive joint motion. Matrix Biol (2010) 1.02
Osteoblast responses one hour after load-induced fluid flow in a three-dimensional porous matrix. Calcif Tissue Int (2005) 1.02
Mechanotransduction and cartilage integrity. Ann N Y Acad Sci (2011) 1.02
Transient exposure to TGF-β3 improves the functional chondrogenesis of MSC-laden hyaluronic acid hydrogels. J Mech Behav Biomed Mater (2012) 0.99
Molecular response of the patellar tendon to fatigue loading explained in the context of the initial induced damage and number of fatigue loading cycles. J Orthop Res (2012) 0.93
Bone formation induced by a novel form of mechanical loading on joint tissue. Biol Sci Space (2004) 0.93
A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. III. Comparative performance characteristics of academic and manufacturers' laboratories. J Rheumatol (2003) 0.93
Events in articular chondrocytes with aging. Curr Osteoporos Rep (2011) 0.91
Mechanical loading: bone remodeling and cartilage maintenance. Curr Osteoporos Rep (2011) 0.90
Overwhelming leukoencephalopathy as the only sign of neuropsychiatric lupus. J Rheumatol (2005) 0.89
Factors modulating expression of Renilla luciferase from control plasmids used in luciferase reporter gene assays. Anal Biochem (2009) 0.88
SU5416 is a potent inhibitor of hepatocyte growth factor receptor (c-Met) and blocks HGF-induced invasiveness of human HepG2 hepatoma cells. J Hepatol (2004) 0.87
Dendritic cell-mediated in vivo bone resorption. J Immunol (2010) 0.87
Age-related carbonylation of fibrocartilage structural proteins drives tissue degenerative modification. Chem Biol (2013) 0.87
Identification of CITED2 as a negative regulator of fracture healing. Biochem Biophys Res Commun (2009) 0.84
Acid ceramidase maintains the chondrogenic phenotype of expanded primary chondrocytes and improves the chondrogenic differentiation of bone marrow-derived mesenchymal stem cells. PLoS One (2013) 0.83
Optimal irrigation and debridement of infected joint implants: an in vitro methicillin-resistant Staphylococcus aureus biofilm model. J Arthroplasty (2011) 0.82
Green tea polyphenol treatment is chondroprotective, anti-inflammatory and palliative in a mouse post-traumatic osteoarthritis model. Arthritis Res Ther (2014) 0.82
Histologic retrieval analysis of a porous tantalum metal implant in an infected primary total knee arthroplasty. J Arthroplasty (2011) 0.82
Unipolar vs bipolar hemostasis in total knee arthroplasty: a prospective randomized trial. J Arthroplasty (2011) 0.80
PMA induces expression from the herpes simplex virus thymidine kinase promoter via the activation of JNK and ERK in the presence of adenoviral E1A proteins. Arch Biochem Biophys (2009) 0.80
A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. II. Potential for quantitation of antibody content. J Rheumatol (2002) 0.78
Vitamin D does not modulate NF-kappaB activity in Jurkat T cells. Immunol Lett (2010) 0.76
Association between autoantibodies to the Ku protein and DPB1*. Arthritis Rheum (2005) 0.76
Mechanical loading: potential preventive and therapeutic strategy for osteoarthritis. J Am Acad Orthop Surg (2014) 0.75
The use of dermabond® as an adjunct to wound closure after total knee arthroplasty: examining immediate post-operative wound drainage. J Arthroplasty (2012) 0.75